Medifast Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 1995
Revenue	1,072	1,599	1,526	934.84	713.67	Upgrade
Revenue Growth (YoY)	-32.94%	4.75%	63.25%	30.99%	42.45%	Upgrade
Cost of Revenue	296.2	458.16	398.49	237.03	176.81	Upgrade
Gross Profit	775.85	1,140	1,128	697.82	536.86	Upgrade
Selling, General & Admin	649.45	955.61	911.36	563.66	445.82	Upgrade
Operating Expenses	649.45	955.61	911.36	563.66	445.82	Upgrade
Operating Income	126.4	184.81	216.24	134.16	91.04	Upgrade
Interest Expense / Income	-2.49	0.7	0.23	-0.25	-1.3	Upgrade
Other Expense / Income	0.1	0.05	-0.12	0.14	-0.03	Upgrade
Pretax Income	128.8	184.06	216.13	134.27	92.36	Upgrade
Income Tax	29.38	40.49	52.1	31.41	14.45	Upgrade
Net Income	99.42	143.57	164.03	102.86	77.92	Upgrade
Net Income Growth	-30.75%	-12.48%	59.47%	32.01%	39.66%	Upgrade
Shares Outstanding (Basic)	11	11	12	12	12	Upgrade
Shares Outstanding (Diluted)	11	11	12	12	12	Upgrade
Shares Change	-3.15%	-4.55%	-0.31%	-2.20%	0.31%	Upgrade
EPS (Basic)	9.13	12.82	14.01	8.74	6.62	Upgrade
EPS (Diluted)	9.10	12.73	13.89	8.68	6.43	Upgrade
EPS Growth	-28.52%	-8.35%	60.02%	34.99%	39.18%	Upgrade
Free Cash Flow	141.17	177.89	60.34	139.31	74.2	Upgrade
Free Cash Flow Per Share	12.97	15.89	5.16	11.84	6.30	Upgrade
Dividend Per Share	4.950	6.560	5.680	4.520	3.380	Upgrade
Dividend Growth	-24.54%	15.49%	25.66%	33.73%	54.34%	Upgrade
Gross Margin	72.37%	71.34%	73.89%	74.65%	75.22%	Upgrade
Operating Margin	11.79%	11.56%	14.17%	14.35%	12.76%	Upgrade
Profit Margin	9.27%	8.98%	10.75%	11.00%	10.92%	Upgrade
Free Cash Flow Margin	13.17%	11.13%	3.95%	14.90%	10.40%	Upgrade
Effective Tax Rate	22.81%	22.00%	24.11%	23.39%	15.64%	Upgrade
EBITDA	144.02	201.84	228.24	141.52	98.32	Upgrade
EBITDA Margin	13.43%	12.63%	14.96%	15.14%	13.78%	Upgrade
Depreciation & Amortization	17.71	17.08	11.88	7.51	7.25	Upgrade
EBIT	126.31	184.76	216.36	134.02	91.07	Upgrade
EBIT Margin	11.78%	11.56%	14.18%	14.34%	12.76%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).